<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Curis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Curis, Inc.

    Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      James Dentzer
    • FOUNDED
      2000
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    ContraFect Corporation

    ContraFect Corporation

    ContraFect is a clinical-stage biotechnology company focused on discovering and de...

    ContraFect is a clinical-stage biotechnology co...

    Filing Type:    PU
    Cancer Genetics, Inc.

    Cancer Genetics, Inc.

    Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and se...

    Cancer Genetics, Inc. is an emerging leader in ...

    Filing Type:    PU
    IDEAYA Biosciences, Inc.

    IDEAYA Biosciences, Inc.

    IDEAYA is an oncology-focused precision medicine company committed to the discover...

    IDEAYA is an oncology-focused precision medicin...

    Filing Type:    PU
    BioLife Solutions, Inc.

    BioLife Solutions, Inc.

    BioLife Solutions is the leading developer, manufacturer and supplier of proprieta...

    BioLife Solutions is the leading developer, man...

    Filing Type:    PU
    Alzamend Neuro, Inc

    Alzamend Neuro, Inc

    Alzamend Neuro™, Inc. (“Alzamend™”) is a biotechnology company dedicated t...

    Alzamend Neuro™, Inc. (“Alzamend™”) is ...

    Filing Type:    RA
    Gritstone Oncology, Inc.

    Gritstone Oncology, Inc.

    Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight mu...

    Gritstone Oncology is developing tumor-specific...

    Filing Type:    PU
    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy ...

    Atara Biotherapeutics is a leading off-the-shel...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Leap Therapeutics, Inc.

    Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-onco...

    Leap Therapeutics (NASDAQ: LPTX) is focused on ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.